Trial Profile
Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Mexiletine (Primary)
- Indications Long QT syndrome
- Focus Diagnostic use
- 09 Dec 2015 New trial record
- 03 Dec 2015 Results published in the Circulation Journal